A trend toward decreased CD4+ T‐cells counts was noted for patients with advancing stage, lymph node metastasis, and distant metastasis, which may imply advancing cancer had escaped immune surveillance and decreased antitumor response. Here, CD4 is linked to metastatic malignant neoplasm in the lymph nodes.